These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18602519)

  • 1. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.
    Benetos A; Thomas F; Pannier B; Bean K; Jégo B; Guize L
    Am J Cardiol; 2008 Jul; 102(2):188-91. PubMed ID: 18602519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions.
    Guize L; Thomas F; Pannier B; Bean K; Jego B; Benetos A
    Diabetes Care; 2007 Sep; 30(9):2381-7. PubMed ID: 17563336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
    Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
    Panagiotakos DB; Pitsavos C; Das UN; Skoumas Y; Stefanadis C
    Diabetes Obes Metab; 2007 Sep; 9(5):660-8. PubMed ID: 17697058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
    J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study.
    Yoon YS; Lee ES; Park C; Lee S; Oh SW
    Int J Obes (Lond); 2007 Mar; 31(3):528-34. PubMed ID: 16865099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
    Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
    Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults.
    Unwin N; Bhopal R; Hayes L; White M; Patel S; Ragoobirsingh D; Alberti G
    Ethn Dis; 2007; 17(3):522-8. PubMed ID: 17985508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.